维普中文期刊产品整合服务
59篇 您的检索式:作者名="CITRON ML"
    题名 作者 年代 出处 被引量
1Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Caneer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oneol2003,21,8:1
2Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C97411Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
3Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain显示文摘Kaplan R Parris WC Citron ML 1998J Clin Oncol1998,16,10:1
4Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain显示文摘Citron ML Kaplan R Parris WC 1998Cancer Investigation1998,16,8:1
5Randomized trial of dose-dense versus conventionally scheduled and sequential versusconcurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:First report of Intergroup trial C9741/Cancer and Leukemia Group B trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
6Long-term administration of controlled release oxycodone tablets for the treatment of cancer pain 显示文摘Citron ML Kaplan R Parris voc 1998Cancer Invest1998,16,8:1
7Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
8Randomized trial of dose-dense versus Conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trail 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
9Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer; first report of intergroup trail C9741/Cancer and leukemia Group B trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Onco12003,21,8:1
10Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain显示文摘Kaplan R Parris WC Citron ML 1998J Clin Oncol1998,16,10:1
11Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
12Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of In-tergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
13Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain显示文摘Citron ML Kaplan R Parris WC 1998Cancer Invest1998,16,8:1
14Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,:1
15Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
16Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer;first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
17Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node -positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
18Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,1,:1
19Randomized trial of dose dense versus conventionally scheduledand sequential versus concurrent combination chemotherapy as postoperative ad juvanttreatmentofnode positive primary breast cancer:first report of inter group trial C9741/cancer and leuke mia group btria 19741 显示文摘Citron ML Beryy DA Cinincione C 2003J Clin Oncol2003,21,8:1
20Randomized trial of dosedense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费